Skip to content
Search

Latest Stories

UWE Bristol and Bedminster Pharmacy to pioneer antimicrobial stewardship

UWE Bristol and Bedminster Pharmacy to pioneer antimicrobial stewardship
The collaboration between UWE Bristol and Bedminster Pharmacy to address societal challenges

In a collaborative effort to combat the escalating threat of antimicrobial resistance (AMR), UWE Bristol and Bedminster Pharmacy have secured grant funding from the UKRI Regional Innovation Fund (RIF) for a groundbreaking 4-month project.

This initiative aims to revolutionise antimicrobial stewardship (AMS) practices at the community pharmacy level, addressing the pressing need for evidence-based approaches in tackling AMR.


With antibiotic misuse contributing significantly to the rise of AMR, the project underscores the vital role of community pharmacies in promoting responsible antibiotic use.

Mr Ade Williams, Superintendent Pharmacist at Bedminster Pharmacy, emphasised the significance of this endeavour, stating:

‘‘The emerging role of Community Pharmacy offering timely accessible clinical interventions, including prescribing antibiotics, will undoubtedly help address the increasing demands on the NHS."

"It is also an exciting opportunity to embed evidence-based AMS principles and practice. Aligning these opportunities effectively is an important challenge to address, and I am grateful for this project," he continued.

Led by Dr Emmanuel Adukwu from the Centre for Research in Biosciences (CRIB) at UWE Bristol, the project promises to deliver innovative solutions to enhance AMS practices.

Dr Adukwu brings extensive expertise in antimicrobial resistance and infection prevention, ensuring a robust scientific foundation for the project.

Joining the endeavour is Obiageli Okolie, a post-doctoral researcher at UWE Bristol, renowned for her contributions to public health research.

Okolie's expertise in antimicrobial resistance and stewardship toolkit development further enriches the project's potential impact.

Reflecting on the collaboration, Mr Ade Williams expressed enthusiasm, affirming his excitement  about "working with the UWE to improve our pharmacy practice and combat antimicrobial resistance together."

Dr Vincent Cheng, a community pharmacist and Lecturer at the University of Bristol, commended the partnership, stating:

"“I am very impressed by the wealth of knowledge and experience brought by the UWE team.

I am confident that they will provide an evidence-based solution to improve pharmacists’ knowledge and practice in the area [antimicrobial resistance]," he added.

The Regional Innovation Fund (RIF) serves as a cornerstone in supporting transformative projects like this.

It fosters collaboration between universities and local industries to address pressing societal challenges.

Through initiatives like this, stakeholders are poised to make meaningful strides in safeguarding public health and promoting sustainable antimicrobial stewardship.

More For You

RPS launches innovative new learning resources for members

With RPS Learn, pharmacists can develop a new skill or improve their understanding of practice or a clinical topic.

Gettyimages

RPS launches new learning resources to boost career development for members

The Royal Pharmaceutical Society (RPS) has launched a new online learning platform designed to support the practice, development and career advancement of its members.

The new platform, called RPS Learn, offers a diverse range of bite-size learning content, available on-demand, catering to all levels — from introductory to advanced and specialist —combining new content with RPS's renowned expertise in education and training to achieve excellence for learners.

Keep ReadingShow less
NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less